Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan

被引:49
|
作者
Ismail, Mohammad [1 ]
Iqbal, Zafar [1 ]
Khattak, Muhammad Bilal [2 ]
Khan, Muhammad Imran [2 ]
Arsalan, Hassan [3 ]
Javaid, Arshad [4 ]
Gul, Qamar [5 ]
Khan, Faramoz [6 ]
机构
[1] Univ Peshawar, Dept Pharm, Peshawar, Khyber Pakhtunk, Pakistan
[2] Ayub Teaching Hosp, Ayub Med Coll, Abbottabad, Khyber Pakhtunk, Pakistan
[3] Sarhad Univ Sci & Informat Technol, Dept Pharm, Peshawar, Pakistan
[4] LRH, PGMI, Peshawar, Pakistan
[5] Univ Malakand, Dept Pharm, Chakdara, Khyber Pakhtunk, Pakistan
[6] Khyber Teaching Hosp, Med Unit B, Peshawar, Pakistan
关键词
Adverse drug interaction; Clinical pharmacy; Drug related problem; Pakistan; Potential drug-drug interaction; Prescriptions screening;
D O I
10.1007/s11096-013-9764-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Multiple drugs therapies may be the potential source of drug-drug interactions that can result in alteration of therapeutic response and/or increase untoward effects of many drugs. Objective To identify the frequency and levels of potential drug-drug interactions (pDDIs) in internal medicine wards and their association with patients' age, gender, length of hospital stay and number of prescribed medications; and to describe management of frequently identified major or moderate pDDIs. Setting Internal medicine wards of two major tertiary care hospitals of Khyber Pakhtunkhwa, Pakistan. Method Micromedex Drug-Reax system was used to screen patient's profiles for pDDIs. Logistic regression was applied to determine the odds ratio for specific risk factors of pDDIs i.e., age, gender, hospital-stay and number of medications. Main outcome measure Overall prevalence and prevalence of contraindicated, major, moderate and minor pDDIs; levels of pDDIs; frequently identified major or moderate interactions; and odds ratios for risk factors. Results Total, 188 interacting drug-combinations were identified that contributed to 675 pDDIs. Of 400 patients, 52.8 % patients were presented with at least one pDDI (overall prevalence), 21.3 % with at least one major-pDDI, and 44.3 % with at least one moderate-pDDI. Of 675 pDDIs, most were of moderate (63.6 %) or major severity (23 %); good (61.2 %) or fair (25.5 %) type of scientific evidence; and delayed onset (50.2 %). Most frequently identified major or moderate interactions resulted in 45.3 % of all pDDIs. Their potential adverse outcomes included hepatotoxicity, bleeding, ototoxicity, nephrotoxicity, hypoglycemia, hyperglycemia, risk of thrombosis, hypotension, cardiac arrhythmias and reduction in therapeutic-effectiveness. There was significant association of the occurrence of pDDIs with patients' age of 60 years or more (OR = 2.1; 95 % CI = 1.3-3.3; p = 0.003), hospital stay of 6 days or longer (OR = 2.6; 95 % CI = 1.5-4.5; p = 0.001), and seven or more number of prescribed medications (OR = 5.9; 95 % CI = 3.6-9.6; p < 0.001). Conclusion The present study has recorded a high prevalence of pDDIs in internal medicine wards. Patients with old age, longer hospital stay and increased number of prescribed medications were at higher risk.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 50 条
  • [1] Potential drug–drug interactions in internal medicine wards in hospital setting in Pakistan
    Mohammad Ismail
    Zafar Iqbal
    Muhammad Bilal Khattak
    Muhammad Imran Khan
    Hassan Arsalan
    Arshad Javaid
    Qamar Gul
    Faramoz Khan
    International Journal of Clinical Pharmacy, 2013, 35 : 455 - 462
  • [2] Recognition and management of potential drug-drug interactions in patients on internal medicine wards
    Vonbach, Priska
    Dubied, Andre
    Beer, Jurg H.
    Kraehenbuehl, Stephan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (11) : 1075 - 1083
  • [3] Prevalence and predictors of potential drug-drug interactions in patients of internal medicine wards of a tertiary care hospital in India
    Bethi, Yugandhar
    Shewade, Deepak Gopal
    Dutta, Tarun Kumar
    Gitanjali, Batmanabane
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2018, 25 (06) : 317 - 321
  • [4] The Prevalence and Severity of Potential Drug-Drug Interactions in Internal Medicine Ward at Soba Teaching Hospital
    Hamadouk, Riham M.
    Alshareif, Einass Mahmoud
    Hamad, Huda M.
    Yousef, Bashir A.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2023, 15 : 149 - 157
  • [5] Recognition and management of potential drug–drug interactions in patients on internal medicine wards
    Priska Vonbach
    André Dubied
    Jürg H. Beer
    Stephan Krähenbühl
    European Journal of Clinical Pharmacology, 2007, 63 : 1075 - 1083
  • [6] EXPOSURE TO POTENTIAL DRUG-DRUG INTERACTIONS IN TEACHING HOSPITAL OF SOUTH PUNJAB, PAKISTAN
    Khan, H. M. S.
    Butt, H.
    Shah, N. H.
    VALUE IN HEALTH, 2014, 17 (07) : A425 - A425
  • [7] Potential drug-drug interactions in the outpatient setting
    Lafata, JE
    Schultz, L
    Simpkins, J
    Chan, KA
    Horn, JR
    Kaatz, S
    Long, C
    Platt, R
    Raebel, MA
    Smith, DH
    Xi, HG
    Yood, MU
    MEDICAL CARE, 2006, 44 (06) : 534 - 541
  • [8] Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine
    Vonbach, Priska
    Dubied, Andre
    Kraehenbuehl, Stephan
    Beer, Juerg H.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2008, 19 (06) : 413 - 420
  • [9] Surveillance of the Potential Drug-Drug Interactions in the Medicine Department of a Tertiary Care Hospital
    Soherwardi, Shahabudin
    Chogtu, Bharti
    Faizal, P.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2012, 6 (07) : 1258 - 1261
  • [10] Evaluation of potential drug-drug interactions in cancer patients at a tertiary care hospital in Pakistan
    Choudary, Nida Ashraf
    Khan, Asad
    Wahid, Abdul
    Abubakar, Muhammad
    Atif, Muhammad
    Ahmad, Nafees
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (03) : 618 - 626